Skip to main content
OpenTrials
Completed

NCT Number: NCT03521466

Medical Student Counseling for Hospitalized Patients Addicted to Tobacco

The purpose of this randomized control trial is two- fold. The primary hypothesis of the study is that smoking cessation counseling delivered through trained medical students will lead to higher rates of abstinence amongst patients in the intervention group, as compared to a control group, when measured by self-reported and biochemical testing at 6 months after enrolment .

The secondary hypothesis is that medical students engaging in a structured curriculum that includes counseling hospitalized smokers will show demonstrable increases in knowledge, confidence in their abilities, and use of smoking cessation techniques in regular practice.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

PSG Institute of Medical Science and Research

Coimbatore, Tamil Nadu, 641004, India

About this study

India is the 2nd largest consumer of tobacco in the world, with 275 million Indians using tobacco. Each hospitalization is an opportunity for providers to motivate their patients to quit. However, the Indian medical curriculum typically offers little training in the skills required to successfully counsel a patient to quit smoking. The investigators hypothesize that trained medical students can increase subsequent quit rates among hospitalized smokers, while acquiring skills in tobacco cessation counseling.

The investigators propose a 2-armed multicenter randomized controlled trial (RCT) that will compare the effectiveness of standard hospital practice versus a medical student-guided smoking cessation program initiated inpatient and continued for three months after discharge. The target study population includes current smokers admitted to the general medicine, pulmonary and cardiology wards. These patients will be randomized to receive either usual care or the intervention. The intervention group will receive both inpatient and longitudinal post-discharge telephone counseling by medical students who have successfully completed a training workshop in tobacco cessation counseling and pharmacotherapy. The students can also recommend nicotine replacement therapy (NRT) to the patient if indicated. The control group will receive counseling and/or NRT at the discretion of the treating physician. They will not receive phone based counseling after discharge.

Patients from both groups will be asked to report their quit status 6 months after enrolment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients age 18-70 years old, who are admitted to the medical, and if required surgical wards.
  • Patients must be current smokers (cigarettes and/or bidis) at the time of admission or report having smoked at all in the last 4 weeks prior to admission (to account for changes in behaviour during illness).
  • Patients living within 10 Km radius of the hospital.

Exclusion criteria

  • Unwilling to participate
  • Patients who use only non-smoked tobacco will be excluded.
  • Patients who are are daily alcohol users, daily cannabis or psychotropic drug users.
  • Patients who do not have a telephone/ unable to follow up
  • Patients unable to understand the local/common language
  • Patients with psychiatric conditions rendering them incapable of interacting with the providers
  • Medically unstable patients
  • Patients with expected hospital stay <24 hours
  • Patients with life expectancy < 12 months
  • Pregnant patients
  • Patients currently participating in a tobacco cessation program
  • Prior participation in this trial during another hospitalisation

Treatment and study plan

Smoking Cessation Counseling

Behavioral

Trained medical students will visit patients inpatient while hospitalized and provide smoking cessation counseling and recommend Nicotine Replacement Therapy. They will continue to follow these patients for 2 months after discharge and provide telephone-based counseling.

Primary outcomes

  1. Biochemically verified 7 day quit rate measured 6 months after enrolment.

    Time frame: 6 months from enrolment

    At 6 months from enrolment, patients will be asked to report abstinence from smoking over the last 7 days (No more than 5 cigarettes in total since quit date); those who claim to have quit will be asked to provide biochemical confirmation by exhaled carbon monoxide breath testing (<10 Parts Per Million will be considered a verified quit attempt).

Secondary outcomes

  1. Biochemically verified 90 day quit rate, measured 6 months after enrolment

    Time frame: 6 months from enrolment

    At 6 months from enrolment, patients will be asked to report abstinence from smoking over the last 90 days; those who claim to have quit will be asked to provide confirmation by exhaled carbon monoxide breath testing (<10 Parts Per Million will be considered a verified quit attempt)

  2. Number of patients achieving a 50% reduction in the number of cigarettes /bidis smoked in a week, measured at 2 and 6 months after enrolment

    Time frame: 2 and 6 months from enrolment

  3. Correlation between verified quit rates at 6 months and FTND scores at enrolment

    Time frame: 6 months from enrolment

  4. Number of patients who report having quit smoking in the last 7 days (irrespective of biochemical verification)

    Time frame: 2 and 6 months from enrolment

  5. Agreement between self reported quit 7 day quit rate and biochemically verified 7 day quit rate, measured at 6 months from enrolment

    Time frame: 6 months from enrolment

  6. No of patients who have refrained from using smokeless tobacco in the last 7 days, measured at 6 months.

    Time frame: 6 months from enrolment

  7. Pre-post analysis of medical student knowledge about counseling techniques and pharmacotherapy

    Time frame: 6 weeks and 12 months after training

    Students will be given a knowledge questionnaire before training and 6 weeks after training. The questionnaire will be scored from 0 to 22, 0 being the lowest and 22 being the highest score.

  8. Qualitative analysis of student attitudes towards smoking cessation counseling

    Time frame: 12 months after training

    Assessed by surveying students who participated in counseling patients. Some questions will be scored on a Likert scale ranging from 1-5; Others are open ended questions and will be analyzed to identify relevant themes.

  9. Qualitative analysis of the feasibility and acceptability of the intervention

    Time frame: 12 months after training

    Students who participate in the trial will receive a survey with open ended questions. The responses will be analysed to identify relevant themes.

Other outcomes

  1. Number of eligible patients that receive inpatient counseling and atleast 3 follow up calls

    Time frame: 2 months from enrolment

    Data from the patient screening and follow up forms will be used to calculate this ratio

  2. Number of patients who use any form of cessation pharmacotherapy within the first 2 months

    Time frame: 2 months from enrolment

    Patients will be asked to report the use of pharmacotherapy during their 2 month follow up call

  3. Number of patients enrolled in the study that are available for follow up at 6 months

    Time frame: 6 months from enrolment

Sponsors and collaborators

Lead sponsor

University Hospitals Cleveland Medical Center

Other

Collaborators

  • Government Calicut Medical College
  • PSG Institute of Medical Science and Research
  • Wayanad Institute of Medical Sciences

Registry information

Official study title

A Randomized Control Trial Evaluating the Effectiveness of a Medical Student Guided Smoking Cessation Program for Hospitalized Smokers in India

Acronym: MS-CHAT

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
May 11, 2018
Registry last updated
Oct 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.